
Currently out of the existing stock ratings of Dylan Dupuis, 4 are a BUY (100%).
Analyst Dylan Dupuis, has had 50% of price targets met with an average potential upside of 40.2%, reached in 112 days on average. Previously, Dylan Dupuis worked at ROTH MKM.
Dylan Dupuis has documented 8 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IVA, Inventiva Sa at 21-Sep-2023.
Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for VKTX (VIKING THERAPEUTICS) on 8/10/2023. The price target of $32 was fulfilled within 188 days with a profit of $17.12 (115.05%), with a performance score of 6.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Sep-2025
$14
$10.86 (345.86%)
$24
16 days ago
(04-Nov-2026)
0/4 (0%)
$10.37 (285.67%)
Buy Since 19-Mar-2026
$18
$14.84 (469.62%)
$13
1 months 19 days ago
(02-Oct-2026)
0/2 (0%)
$14.44 (405.62%)
Buy Since 27-Oct-2023
$21
$17.86 (568.79%)
$20
1 months 23 days ago
(29-Sep-2026)
0/5 (0%)
$17.71 (538.30%)
Buy Since 27-Aug-2025
$26
$22.86 (728.03%)
$26
2 months 5 days ago
(16-Sep-2026)
0/3 (0%)
$22.21 (586.02%)
Buy Since 17-Nov-2025
$14
$10.86 (345.86%)
$11
2 months 6 days ago
(15-Sep-2026)
0/3 (0%)
$10.14 (262.69%)